Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #62,951 to #63,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Glucose-6-phosphate dehydrogenase deficiency (patient information) (5 revisions)
  2. Glucose-6-phosphate dehydrogenase deficiency CT (5 revisions)
  3. Glucose-6-phosphate dehydrogenase deficiency MRI (5 revisions)
  4. Glucose-6-phosphate dehydrogenase deficiency differential diagnosis (5 revisions)
  5. Glucose-insulin-potassium infusion (5 revisions)
  6. Glutaraldehyde (5 revisions)
  7. Glycogen phosphorylase (5 revisions)
  8. Glycogen storage disease type III diagnostic study of choice (5 revisions)
  9. Glycogen storage disease type III overview (5 revisions)
  10. Glycogen storage disease type III physical examination (5 revisions)
  11. Glycogen storage disease type III screening (5 revisions)
  12. Glycogen storage disease type II (patient information) (5 revisions)
  13. Glycogen storage disease type II MRI (5 revisions)
  14. Glycogen storage disease type II other imaging findings (5 revisions)
  15. Glycogen storage disease type I differential diagnosis (5 revisions)
  16. Glycogen storage disease type I risk factors (5 revisions)
  17. Glycoprotein Ib (5 revisions)
  18. Goal-directed therapy (5 revisions)
  19. Goiter electrocardiogram (5 revisions)
  20. Gonadoblastoma other diagnostic studies (5 revisions)
  21. Gonadoblastoma primary prevention (5 revisions)
  22. Gonadoblastoma secondary prevention (5 revisions)
  23. Gonorrhea case study one (5 revisions)
  24. Goodpasture syndrome other imaging findings (5 revisions)
  25. Gout case study one (5 revisions)
  26. Gout resident survival guide (5 revisions)
  27. Graft-versus-host disease secondary prevention (5 revisions)
  28. Graft versus host (5 revisions)
  29. Graham-Steell murmur (5 revisions)
  30. Granulomatosis with polyangiitis cost-effectiveness of therapy (5 revisions)
  31. Granulomatosis with polyangiitis secondary prevention (5 revisions)
  32. Granulomatous amoebic encephalitis causes (5 revisions)
  33. Granulosa cell tumour primary prevention (5 revisions)
  34. Graves' disease epidemiology and demographics (5 revisions)
  35. Griseofulvin (patient information) (5 revisions)
  36. Griseofulvin indications and usage (5 revisions)
  37. Group B streptococcal infection historical perspective (5 revisions)
  38. Growth hormone deficiency other imaging findings (5 revisions)
  39. Guanoclor (5 revisions)
  40. Guidelines for the management of aSAH (surgical and endovascular methods of treatment of ruptured cerebral aneurysms) (5 revisions)
  41. Guidelines for the management of cerebral vasospasm and DCI associated with aSAH (5 revisions)
  42. Guillain-Barré syndrome diagnosis (5 revisions)
  43. Guillain-Barré syndrome other imaging findings (5 revisions)
  44. Gut brain axis (5 revisions)
  45. HELLP syndrome differential diagnosis (5 revisions)
  46. HELLP syndrome natural history, complications and prognosis (5 revisions)
  47. HELLP syndrome physical examination (5 revisions)
  48. HIF1A (5 revisions)
  49. Insulin detemir (5 revisions)
  50. Insulinoma cost-effectiveness of therapy (5 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"